Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Streamlining deep brain stimulation surgery by reversing the staging order

Producción científica: Articlerevisión exhaustiva

8 Citas (Scopus)

Resumen

Deep brain stimulation (DBS) is approved for several clinical indications; however, the sequencing of DBS surgery and the timeline for implementing stimulation therapy are not standardized. In over 140 cases so far, the authors have reversed the sequencing for staged implantation of DBS systems that was conducive to minimizing patient anxiety and discomfort while providing the opportunity to shorten the time between implantation and programming for therapeutic management of symptoms. Stage I was performed with the patient under general anesthesia and consisted of implantation of the pulse generator and lead extensions and placement of the bur holes. Stage II was completed 1-7 days later, using only local anesthesia, and included stereotactic frame-based microelectrode recordings, semi-microstimulation and macrostimulation, and testing and placement of the stimulating electrodes. Stage I lasted approximately 90 minutes, whereas Stage II lasted approximately 230 minutes. All patients tolerated the procedures and received a complete implanted system. Deep brain stimulation therapy was typically initiated on the same day as lead implantation. When sequencing was reversed and bur holes were placed during the first stage while a patient was under general anesthesia, the patient was able to tolerate the second awake stage and was able to begin stimulation therapy within 48 hours of the second stage.

Idioma originalEnglish
Páginas (desde-hasta)1042-1047
Número de páginas6
PublicaciónJournal of Neurosurgery
Volumen122
N.º5
DOI
EstadoPublished - may 2015

Nota bibliográfica

Publisher Copyright:
© AANS, 2015.

Financiación

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Dr. van Horne is a consultant for Medtronic. Support was provided in part by University of Kentucky start-up funds (C.vH.) and the National Center for Advancing Translational Sciences (Grant No. UL1TR000117). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)UL1TR000117
University of Kentucky

    ASJC Scopus subject areas

    • Surgery
    • Clinical Neurology

    Huella

    Profundice en los temas de investigación de 'Streamlining deep brain stimulation surgery by reversing the staging order'. En conjunto forman una huella única.

    Citar esto